Paradigm Financial Advisors Has Boosted Cvs (CVS) Position By $1.10 Million; 27 Analysts Covering Oracle (ORCL)

May 25, 2018 - By Vivian Park

Oracle Corporation (NYSE:ORCL) Logo

Among 43 analysts covering Oracle (NYSE:ORCL), 27 have Buy rating, 0 Sell and 16 Hold. Therefore 63% are positive. Oracle had 116 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Saturday, October 10 by Drexel Hamilton. RBC Capital Markets maintained the shares of ORCL in report on Thursday, March 15 with “Hold” rating. Cowen & Co initiated the stock with “Outperform” rating in Friday, June 24 report. The firm earned “Market Perform” rating on Thursday, March 16 by JMP Securities. BMO Capital Markets maintained the shares of ORCL in report on Monday, October 2 with “Buy” rating. The firm has “Buy” rating given on Friday, August 25 by Jefferies. As per Wednesday, November 11, the company rating was downgraded by Morgan Stanley. KeyBanc Capital Markets downgraded the shares of ORCL in report on Tuesday, March 20 to “Sector Weight” rating. Morgan Stanley upgraded Oracle Corporation (NYSE:ORCL) on Wednesday, January 3 to “Overweight” rating. The firm has “Outperform” rating given on Wednesday, January 11 by Wells Fargo. See Oracle Corporation (NYSE:ORCL) latest ratings:

17/05/2018 Broker: Monness Rating: Hold
11/04/2018 Broker: Monness Crespi & Hardt Rating: Neutral Initiates Coverage On
20/03/2018 Broker: MUFG Securities Americas Inc Rating: Buy New Target: $58.0
20/03/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $55 New Target: $53 Maintain
20/03/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $62 New Target: $60 Maintain
20/03/2018 Broker: Bank of America Old Rating: Buy New Rating: Neutral Downgrade
20/03/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Hold Downgrade
20/03/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Sector Weight Downgrade
15/03/2018 Broker: Cleveland Rating: Hold
15/03/2018 Broker: RBC Capital Markets Rating: Hold New Target: $55.0 Maintain

Paradigm Financial Advisors Llc increased Cvs Corp (CVS) stake by 132.97% reported in 2017Q4 SEC filing. Paradigm Financial Advisors Llc acquired 15,256 shares as Cvs Corp (CVS)’s stock declined 17.45%. The Paradigm Financial Advisors Llc holds 26,729 shares with $1.94 million value, up from 11,473 last quarter. Cvs Corp now has $66.20B valuation. The stock decreased 0.69% or $0.45 during the last trading session, reaching $65.12. About 4.71 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 25, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

The stock decreased 0.94% or $0.44 during the last trading session, reaching $46.46. About 12.50M shares traded. Oracle Corporation (NYSE:ORCL) has risen 1.20% since May 25, 2017 and is uptrending. It has underperformed by 10.35% the S&P500.

Oracle Corporation develops, manufactures, markets, sells, hosts, and supports application, platform, and infrastructure technologies for information technology environments worldwide. The company has market cap of $189.66 billion. It provides services in three primary layers of the cloud: Software as a Service, Platform as a Service, and Infrastructure as a Service. It has a 54.34 P/E ratio. The firm licenses its Oracle Database software, which enables storage, retrieval, and manipulation of data; and Oracle Fusion Middleware software to build, deploy, secure, access, and integrate business applications, as well as automate their business processes.

Investors sentiment increased to 1.15 in 2017 Q4. Its up 0.02, from 1.13 in 2017Q3. It improved, as 80 investors sold Oracle Corporation shares while 488 reduced holdings. 126 funds opened positions while 526 raised stakes. 2.29 billion shares or 1.37% less from 2.32 billion shares in 2017Q3 were reported. Headinvest Limited invested 0.79% of its portfolio in Oracle Corporation (NYSE:ORCL). 527,477 were accumulated by Cibc Asset Mngmt. Veritas Asset Management Limited Liability Partnership stated it has 2.81% in Oracle Corporation (NYSE:ORCL). Huber Cap Mgmt Limited Liability owns 551,100 shares. Wealthtrust reported 3,354 shares stake. 10,477 were reported by Blue Financial Capital. Riverbridge Ptnrs Ltd Liability invested 0% in Oracle Corporation (NYSE:ORCL). Granite Invest Prtnrs Limited Co holds 0.18% of its portfolio in Oracle Corporation (NYSE:ORCL) for 59,200 shares. Virginia Retirement Et Al holds 390,100 shares or 0.22% of its portfolio. Regal Invest Advsr Lc holds 0.45% of its portfolio in Oracle Corporation (NYSE:ORCL) for 42,436 shares. Kcm Investment Ltd Limited Liability Company stated it has 84,169 shares. Fincl Counselors Incorporated invested in 0.09% or 43,597 shares. Moreover, Cohen Management Incorporated has 1.37% invested in Oracle Corporation (NYSE:ORCL). Farmers Financial Bank has 5,280 shares. Invsts Asset Management Of Georgia Inc Ga Adv reported 4,980 shares stake.

More notable recent Oracle Corporation (NYSE:ORCL) news were published by: Seekingalpha.com which released: “Oracle To Acquire DataScience For Workflow Technologies” on May 22, 2018, also Seekingalpha.com with their article: “The Information: Oracle’s aggressive cloud sales tactics push away customers” published on May 22, 2018, Seekingalpha.com published: “Oracle buys DataScience.com” on May 16, 2018. More interesting news about Oracle Corporation (NYSE:ORCL) were released by: Seekingalpha.com and their article: “What Does Cap Ex Spending Tell Us About Oracle’s Future Cloud Growth?” published on May 23, 2018 as well as Bizjournals.com‘s news article titled: “Department of Defense CIO on cloud tech: One solution won’t ‘solve for all'” with publication date: May 24, 2018.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “We Are Playing The CVS Hand” on May 11, 2018, also Fool.com with their article: “5 Things You’ll Want to Know About CVS Health’s Plans for 2018 and Beyond” published on May 04, 2018, Seekingalpha.com published: “Trade Mistake 3: CVS Boredom Trade” on May 09, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Streetinsider.com and their article: “Pfizer to pay $23.85 million to settle US co-payment kickback probe” published on May 24, 2018 as well as Seekingalpha.com‘s news article titled: “CVS: Going Long, And Understanding The Aetna Deal” with publication date: April 30, 2018.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. Oppenheimer maintained CVS Health Corporation (NYSE:CVS) rating on Thursday, December 17. Oppenheimer has “Outperform” rating and $117 target. The company was downgraded on Monday, June 20 by Morgan Stanley. The rating was initiated by Barclays Capital with “Overweight” on Friday, December 18. As per Tuesday, November 7, the company rating was maintained by Jefferies. Bank of America maintained the shares of CVS in report on Wednesday, April 11 with “Buy” rating. Robert W. Baird maintained the shares of CVS in report on Thursday, January 4 with “Hold” rating. The firm has “Buy” rating given on Friday, November 10 by Needham. On Wednesday, May 2 the stock rating was maintained by Oppenheimer with “Buy”. Mizuho maintained CVS Health Corporation (NYSE:CVS) rating on Wednesday, November 9. Mizuho has “Buy” rating and $90 target. The stock of CVS Health Corporation (NYSE:CVS) has “Outperform” rating given on Monday, November 2 by Oppenheimer.

Since February 16, 2018, it had 2 buys, and 1 insider sale for $713,454 activity. The insider DORMAN DAVID W bought 24,300 shares worth $1.51 million. Another trade for 19,965 shares valued at $1.42M was sold by Foulkes Helena. BROWN C DAVID II bought $619,900 worth of CVS Health Corporation (NYSE:CVS) on Friday, May 4.

Investors sentiment decreased to 0.72 in Q4 2017. Its down 0.16, from 0.88 in 2017Q3. It turned negative, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Community National Bank Na accumulated 20,300 shares. Senator Invest Limited Partnership stated it has 1.94% in CVS Health Corporation (NYSE:CVS). Richard C Young And Co Ltd, a Rhode Island-based fund reported 81,242 shares. Lodestar Counsel Ltd Liability Corp Il reported 55,444 shares or 0.46% of all its holdings. 1,093 are owned by Parkside Financial Bank & Tru. Visionary Asset Mngmt Incorporated, Texas-based fund reported 3,646 shares. 3,472 were reported by First Bank & Trust Sioux Falls. Regent Management Ltd Llc reported 1.6% in CVS Health Corporation (NYSE:CVS). Cypress Cap Grp reported 17,648 shares stake. Leavell Invest Mngmt holds 0.05% or 5,753 shares in its portfolio. Accuvest Glob Advsr invested in 0% or 75 shares. Bessemer reported 12,244 shares. Vigilant Cap Mgmt Ltd reported 56,338 shares. Exane Derivatives holds 11,645 shares or 0.15% of its portfolio. 12,861 are owned by White Pine Limited Company.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>